Scholarly Index
Marcus Zervos
Henry Ford Health System; 22,892 total citations; 415 total publications; best world rank #40
Henry Ford Health System
22,892Total citations
415Total publications
82H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Antimicrobial Resistance in Staphylococcus | Lifetime | 40 | US 25 | 99.70 |
| Bacterial Identification and Susceptibility Testing | Lifetime | 43 | US 19 | 99.67 |
| Streptococcal Infections and Treatments | Lifetime | 128 | US 73 | 99.05 |
| Antibiotics Pharmacokinetics and Efficacy | Lifetime | 387 | US 151 | 98.12 |
| Antibiotic Resistance in Bacteria | Lifetime | 544 | US 164 | 98.40 |
| Pneumonia and Respiratory Infections | Lifetime | 614 | US 247 | 97.98 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 778 | US 335 | 97.19 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 497 | US 217 | 96.57 |
| Antibiotic Use and Resistance | Lifetime | 604 | US 208 | 96.54 |
| Antifungal resistance and susceptibility | Lifetime | 898 | US 325 | 96.00 |
| Nosocomial Infections in ICU | Lifetime | 411 | US 148 | 96.23 |
| Enterobacteriaceae and Cronobacter Research | Lifetime | 384 | US 86 | 91.53 |
| Infection Control in Healthcare | Lifetime | 567 | US 248 | 87.33 |
| Antibiotic Use and Resistance | 2021-2025 | 658 | US 150 | 88.83 |
| Nosocomial Infections in ICU | 2021-2025 | 412 | US 84 | 80.39 |